South-East Asia (WHO region) vs Switzerland: Hypertension effective treatment coverage (controlled hypertension)
South-East Asia (WHO region)
13.6%
in 2019
Switzerland
36.8%
in 2019
South-East Asia (WHO region) rank
9th
Switzerland rank
12th
Hypertension effective treatment coverage (controlled hypertension) over time
- South-East Asia (WHO region)
- Switzerland
How they compare
Switzerland currently reports 36.8% against 13.6% in South-East Asia (WHO region), a difference of 23.2%.
That makes Switzerland's figure about 2.7 times South-East Asia (WHO region)'s.
Across all 30 years both countries report, Switzerland has been ahead every year.
South-East Asia (WHO region) ranks 9th and Switzerland ranks 12th of 11 groups.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.5% | 9.7% | 7.2% | Switzerland |
| 2000s | 5.8% | 20.3% | 14.5% | Switzerland |
| 2010s | 10.9% | 32.8% | 21.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), South-East Asia (WHO region) or Switzerland?
- Switzerland, at 36.8% against 13.6% in South-East Asia (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between South-East Asia (WHO region) and Switzerland?
- 23.2%, with Switzerland ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Switzerland?
- 30 years are reported by both, from 1990 to 2019.
- How do South-East Asia (WHO region) and Switzerland rank globally for hypertension effective treatment coverage (controlled hypertension)?
- South-East Asia (WHO region) ranks 9th and Switzerland ranks 12th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.